Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Walsh, B. T. Articles by Chally, M. K. Search for Related Content PubMed Citation Articles by Walsh, B. T. Articles by Chally, M. K. Eating Disorders Behavior Therapy Cognitive Therapy Antidepressants

Fluoxetine for Bulimia Nervosa Following Poor Response to Psychotherapy

OBJECTIVE: This was an investigation of whether treatment with fluoxetine is useful for individuals with bulimia nervosa who do not respond to psychotherapy or relapse afterward. METHOD: Twenty-two patients with bulimia nervosa who had not responded to, or had relapsed following, a course of cognitive behavior therapy or interpersonal psychotherapy were randomly assigned to receive placebo (N=9) or fluoxetine (60 mg/day, N=13) for 8 weeks. RESULTS: The median frequency of binge eating in the previous 28 days declined from 22 to four episodes in the fluoxetine group but increased from 15 to 18 episodes in the placebo group. Similarly, purging frequency in the previous 28 days declined from 30 to six episodes in the fluoxetine group but increased from 15 to 38 episodes in the placebo group. CONCLUSIONS: Fluoxetine may be a useful intervention for patients with bulimia nervosa who have not responded adequately to psychological treatment.

This article has been cited by other articles:

				J. Yager, M. J. Devlin, K. A. Halmi, D. B. Herzog, J. E. Mitchell, P. S. Powers, and K. J. Zerbe Eating Disorders Focus, October 1, 2005; 3(4): 503 - 510. [Abstract] [Full Text] [PDF]

				J. Yager, M. J. Devlin, K. A. Halmi, D. B. Herzog, J. E. Mitchell, P. S. Powers, and K. J. Zerbe Guideline Watch: Practice Guideline for the Treatment of Patients With Eating Disorders, 2nd Edition Focus, October 1, 2005; 3(4): 546 - 551. [Full Text] [PDF]

				S. Fassino, G. A. Daga, S. Boggio, L. Garzaro, and A. Piero Use of Reboxetine in Bulimia Nervosa: A Pilot Study J Psychopharmacol, September 1, 2004; 18(3): 423 - 428. [Abstract] [PDF]

				D. N. D'Souza, Y. Zhang, F. Garcia, G. Battaglia, and L. D. Van de Kar Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R390 - R397. [Abstract] [Full Text] [PDF]

				K. A. Halmi, W. S. Agras, J. Mitchell, G. T. Wilson, S. Crow, S. W. Bryson, and H. Kraemer Relapse Predictors of Patients With Bulimia Nervosa Who Achieved Abstinence Through Cognitive Behavioral Therapy Arch Gen Psychiatry, December 1, 2002; 59(12): 1105 - 1109. [Abstract] [Full Text] [PDF]

				P. J Hay and J. Bacaltchuk Extracts from ""Clinical Evidence"": Bulimia nervosa BMJ, July 7, 2001; 323(7303): 33 - 37. [Full Text] [PDF]

				Psychotherapy for Bulimia: Predicting and Addressing Treatment Failure Journal Watch Women's Health, September 18, 2000; 2000(918): 6 - 6. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us